Integrated procedure for determination of endocrine-disrupting activity in surface waters and sediments by use of the biological technique recombinant yeast assay and chemical analysis by LC-ESI-MS

被引:152
作者
Céspedes, R
Petrovic, M
Raldúa, D
Saura, U
Piña, B
Lacorte, S
Viana, P
Barceló, D
机构
[1] CSIC, IIQAB, Dept Environm Chem, ES-08034 Barcelona, Spain
[2] CSIC, IBM, Dept Mol Biol, ES-08034 Barcelona, Spain
[3] Inst Ambiente, P-2720 Amadora, Portugal
关键词
endocrine-disrupting compounds; estrogenicity; recombinant yeast assay; liquid chromatography-mass spectrometry;
D O I
10.1007/s00216-003-2303-5
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
An integrated procedure using mass spectrometry and molecular biology for determination of estrogenicity in natural waters and sediments is reported. Solid-phase extraction (SPE) and pressurized-liquid extraction (PLE), respectively, were used for isolation of endocrine-disrupting compounds (EDC) from surface waters and sediments, followed by liquid chromatography-mass spectrometry using an electrospray interface (LC-ESI-MS). Twenty seven EDC were determined: non-ionic surfactants (nonylphenol ethoxylate), alkylphenols (e.g. nonylphenol and octylphenol), bisphenol A, phthalates, and natural and synthetic steroid sex hormones. Limits of detection varied from 0.02 to 0.22 mug L-1 and from 1 to 10 mug kg(-1) in water and sediments, respectively. Recoveries ranged from 65 to 125% and 73 to 97% for waters and sediments, respectively. In addition to LC-ESI-MS determination, extracts obtained by SPE and PLE were analyzed by the recombinant yeast assay (RYA) to assess total estrogenic activity. This bioassay detects natural estrogens and xenoestrogens, producing a quantitative measurement of EDC irrespective of the identity of the chemical responsible for the activity. As a novelty, a relative estrogenicity factor was determined for 19 analytes with EC50 values ranging from 10(-10) to 10(-9) mol L-1 for synthetic estrogens, from 10(-7) to 10(-5) mol L-1 for alkylphenol derivatives, and from 10(-5) to 10(-4) mol L-1 for phthalates and benzothiazoles. By use of this integrated chemical-ecotoxicological approach good correlation was usually established between chemical composition and estrogenic effects for surface water and sediment samples from Portugal. Estrogenic activity observed was mainly attributed to the presence of nonylphenolic compounds (with concentrations of NP ranging from 0.1 up to 44 mug L-1 in waters and up to 1172 mug kg(-1) in sediments), and to the sporadic presence of estrogens, detected at ng L-1 levels.
引用
收藏
页码:697 / 708
页数:12
相关论文
共 77 条
[1]   Estrogenic metabolites of alkylphenol polyethoxylates in secondary sewage effluents and rivers [J].
Ahel, M ;
Molnar, E ;
Ibric, S ;
Giger, W .
WATER SCIENCE AND TECHNOLOGY, 2000, 42 (7-8) :15-22
[2]   PARTITIONING OF ALKYLPHENOLS AND ALKYLPHENOL POLYETHOXYLATES BETWEEN WATER AND ORGANIC-SOLVENTS [J].
AHEL, M ;
GIGER, W .
CHEMOSPHERE, 1993, 26 (08) :1471-1478
[3]   Defining the molecular and cellular basis of toxicity using comparative models [J].
Ballatori, N ;
Villalobos, AR .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2002, 183 (03) :207-220
[4]   Monitoring natural and synthetic estrogens at activated sludge sewage treatment plants and in a receiving river water [J].
Baronti, C ;
Curini, R ;
D'Ascenzo, G ;
Di Corcia, A ;
Gentili, A ;
Samperi, R .
ENVIRONMENTAL SCIENCE & TECHNOLOGY, 2000, 34 (24) :5059-5066
[5]   Xenoestrogens: The emerging story of bisphenol A [J].
Ben-Jonathan, N ;
Steinmetz, R .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 1998, 9 (03) :124-128
[6]  
BROTONS JA, 1995, ENVIRON HEALTH PERSP, V103, P608, DOI 10.2307/3432439
[7]   DEVELOPMENTAL EFFECTS OF ENDOCRINE-DISRUPTING CHEMICALS IN WILDLIFE AND HUMANS [J].
COLBORN, T ;
SAAL, FSV ;
SOTO, AM .
ENVIRONMENTAL HEALTH PERSPECTIVES, 1993, 101 (05) :378-384
[8]   ENVIRONMENTAL ESTROGENS - HEALTH IMPLICATIONS FOR HUMANS AND WILDLIFE [J].
COLBORN, T .
ENVIRONMENTAL HEALTH PERSPECTIVES, 1995, 103 :135-136
[9]   The estrogenic and antiestrogenic activities of phytochemicals with human estrogen receptor expressed in yeast [J].
Collins, BM ;
McLachlan, JA ;
Arnold, SF .
STEROIDS, 1997, 62 (04) :365-372
[10]  
*COMM EUR COMM, 1997, EUR WORKSH IMP END D